Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00127842

Ligand	Ligand name	Chain	PDB	Tanimoto
BFB	N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE	A	2DW5	0.72
C71	N-[4-(AMINOMETHYL)-1,1-DIOXIDOTETRAHYDRO-2H-THIOPYRAN-4-YL]-3-(1-METHYLCYCLOPENTYL)-N~2~-[(1E)-N-(PHENYLSULFONYL)ETHANIMIDOYL]-L-ALANINAMIDE	A,B	2FRQ	0.71
PNM	OPEN FORM - PENICILLIN G	A	1GHP	0.7
PNM	OPEN FORM - PENICILLIN G	A	1PWC	0.7
PNM	OPEN FORM - PENICILLIN G	A	1IYQ	0.7
PNM	OPEN FORM - PENICILLIN G	A	1FQG	0.7
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2J8Y	0.7
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2JBF	0.7
PNM	OPEN FORM - PENICILLIN G	A	2EX8	0.7
DI5	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	H	1LHG	0.72
DP7	AC-(D)PHE-PRO-BOROARG-OH	H	1LHC	0.73
MIN	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	H,I	1TOM	0.72
G23	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	A	1HTE	0.71
27U	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	H,I	2ZHQ	0.71
SP9	N-{(1R)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNT	0.71
F20	N-BENZOYL-L-PHENYLALANYL-4-[(5S)-1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN-5-YL]-L-PHENYLALANINAMIDE	A	2CMA	0.7
RA8	N-(BENZYLSULFONYL)-L-LEUCYL-N-(4-{[AMINO(IMINO)METHYL]AMINO}BUTYL)-L-PROLINAMIDE	H,I	1YPL	0.71
IZD	ISOTHIAZOLIDINONE ANALOG	A	2CM7	0.73
T29	TRI166 (BIFUNCTIONAL BORONATE INHIBITOR)	H	1A3B	0.78
352	(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one	A,B,C,D	3EY4	0.72
FA4	SM-25453	A,B	2D1O	0.72
FA4	SM-25453	A,B	2D1N	0.72
FAF	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	B,C	1GGD	0.71
D7P	D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]-D-ORNITHINAMIDE	A,B	1RS7	0.71
D7P	D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]-D-ORNITHINAMIDE	A,B	1RS9	0.71
50U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	A	2ZDK	0.7
50U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	H,I	2ZG0	0.7
53U	D-phenylalanyl-N-benzyl-L-prolinamide	H,I	2ZFF	0.71
SP8	N-{(1S)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNS	0.71
OIR	N-(3-PHENYL-2-SULFANYLPROPANOYL)PHENYLALANYLALANINE	A	1R1J	0.71
32U	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	H,I	2ZDA	0.71
R56	5-OXO-6-PHENYLMETHANESULFONYLAMINO-HEXAHYDRO-THIAZOLO[3,2-A]PYRIDINE-3-CARBOXYLIC ACID (3-GUANIDINO-PROPYL)-AMIDE	F	1BHX	0.71
4MC	(Z)-N-(5-GUANIDINO-1-OXO-1-(5-PHENYL-1-(PHENYLSULFONYL)PENT-1-EN-3-YLAMINO)PENTAN-2-YL)-4-METHYLPIPERAZINE-1-CARBOXAMIDE	A,C	2EFM	0.71
JNH	1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE	I,J	2AJL	0.7
BAG	N-[(E)-2-AMINO-1-(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)-2-HYDROXYVINYL]BENZAMIDE	A	1WDA	0.72
44U	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	B,D	3DA9	0.7
DI4	AC-(D)PHE-PRO-BOROHOMOLYS-OH	H	1LHF	0.71
0Z6	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-phenylalaninamide	H,L	3ELA	0.7
L86	(11S)-11-BENZYL-6-CHLORO-1,2,10,11,12,13,14,15,16,17,18,19-DODECAHYDRO-5,9-METHANO-2,5,8,10,13,17-BENZOHEXAAZACYCLOHENICOSINE-3,24-DIONE	A,B	1NM6	0.7
F1H	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	A	2ZJH	0.73
49U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	A	2ZDN	0.71
49U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	H,I	2ZHF	0.71
DI3	AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH	H	1LHE	0.71
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1R1I	0.71
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1QF1	0.71
A21	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	A,B,C,D	3BZU	0.74
DI2	AC-(D)PHE-PRO-BOROLYS-OH	H	1LHD	0.71